BOSTON--(BUSINESS WIRE)--Netcapital Inc. (the “Company”) (NASDAQ: NCPL, NCPLW), a digital private capital markets ecosystem, today announced the entry into definitive agreements for the immediate ...
When sued to enforce these warrant agreements, these issuers assert that the plaintiffs operate as 'unregistered dealers' and ...
TORONTO, April 17, 2025 (GLOBE NEWSWIRE) -- Inventus Mining Corp. (TSXV: IVS) (“Inventus” or the “Company”) is pleased to announce that the Company will make an application to the TSX Venture Exchange ...
SALT LAKE CITY, Utah, Sept. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics innovator specializing in biomedical applications of ...
Helius Medical Technologies, Inc. announced agreements with warrant holders to exercise nearly 4.97 million shares of common stock at a reduced price of $0.751 per share, generating approximately $3.7 ...
NEWTOWN, Pa., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic ...
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN ...
VANCOUVER, BC / ACCESSWIRE / October 6, 2023 / Tectonic Metals Inc. (TECT:TSXV); (TETOF:OTCQB);(T15B:FSE) ("Tectonic" or the "Company"), today announced that the Company will seek to further fund the ...
Packaging Gateway on MSN
NYSE to delist Ardagh Metal Packaging warrants over low price
The NYSE cites an “abnormally low selling price” levels for the securities, which trade under the symbol AMBP.WS.
CORVALLIS, Ore.--(BUSINESS WIRE)--NuScale Power Corporation (NYSE: SMR), the industry-leading provider of proprietary and innovative advanced nuclear small modular reactor (SMR) technology, today ...
Carlsbad, CA, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (PALI) (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback